Abstract:Intrauterine device is a popular cost-effective method of contraception known worldwide. It is extremely effective, with pregnancy rates comparable to tubal ligation (5-year cumulative rate varying from 0.5 to 1.1). LNG-IUS increases in popularity and may be used as the method of choice for adults because it offers non-contraceptive benefits: slight menstrual bleeding, decreased number of incidents of dysmenorrhea, and reduced pain associated with endometriosis. The levonorgestrel-releasing intrauterine system (LNG-IUS) provides a release rate of 20 microg/24 h of levonorgestrel. The hormone released from the intrauterine device causes some systemic changes, however local effects, such as glandular atrophy and stromal decidualization, in addition to foreign body reaction, are dominant. According to the Food and Drug Administration regulations, category X was assigned to LNG. The use of the product is contraindicated in women who are or may become pregnant. We report a case of a 30-year old woman who has already been pregnant before the insertion of a levonorgestrel -releasing intrauterine system (LNG-IUS). The patient was lactating after the previous pregnancy the first menstruation had not appeared yet. The patient planned to have the IUD inserted but she missed her appointed visits twice. The third visit took place 8 weeks postpartum. During that visit, the doctor asked her about the possibility of being pregnant, but the patient denied. The gynecologist inserted the intrauterine device and performed transvaginal ultrasound examination. The location of LNG-IUS was proper and there was no gestation sac in the uterine cavity. After the next six weeks, transvaginal ultrasonography and manual examination showed an intrauterine pregnancy at 8 weeks of gestation. The intrauterine device was not detectable in the uterine cavity by ultrasound, and the IUD strings were not visualized in the vagina. It was impossible to remove the device without causing miscarriage. Other risks during pregnancy were connected with potential masculinisation of the fetus by levonorgestrel, premature delivery and preterm rupture of the membranes. The pregnancy progressed normally and the delivery was uncomplicated. A female infant was born without congenital abnormalities. The pediatrician did not find any indices of infection. The IUD was found in fetal membranes. The postpartum recovery was uneventful. This case report demonstrates that a healthy infant can be delivered at term with an IUS in situ, probably without causing any abnormalities. Due to that fact that adverse effects of fetal exposure to the LNG-IUS have not been yet established, the exclusion of pregnancy before IUD insertion is strictly indicated.

Management of the malpositioned levonorgestrel-releasing intrauterine system

Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system

Unilateral hydroureteronephrosis after introduction of a levonorgestrel-releasing intrauterine system: a case report and literature review

Pregnancy in a patient with a displaced levonorgestrel-releasing intrauterine system: a case report

Importance of abdominal X-ray to confirm the position of levonorgestrel-releasing intrauterine system: A case report

[Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report]

The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: A case report

Ease of removal of malpositioned IUDs: a retrospective cohort study

Ultrasound-guided repositioning technique for partially expelled intrauterine device: descriptive feasibility study

Transmural migration and perforation of a levonorgestrel intrauterine system: a case report and review of the literature

Postplacental placement of intrauterine devices: A randomized clinical trial

Suture-fixation of a levonorgestrel-releasing intrauterine device under hysteroscopic guidance

Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception

Effectiveness, safety and overall satisfaction of early postpartum placement of hormonal IUD compared with standard procedure: An open-label, randomized, multicenter study

The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy

One-year follow up on post-placental IUD insertion: A randomized clinical trial

Levonorgestrel-releasing intra-uterine systems as female contraceptives

Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system

[A prospective cohort study on the impact of placement timing of LNG-IUS for adenomyosis]

Expulsion and continuation rates of the levonorgestrel 52 mg intrauterine system was similar among nulligravid and parous users

Preliminary report on the use of a levonorgestrel intrauterine system for the treatment of intermenstrual bleeding due to previous cesarean delivery scar defect